Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $1.01 billion. The enterprise value is $1.03 million.
Important Dates
The next confirmed earnings date is Tuesday, February 25, 2025, after market close.
Earnings Date | Feb 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RCUS has 91.51 million shares outstanding. The number of shares has increased by 17.25% in one year.
Current Share Class | 91.51M |
Shares Outstanding | 91.51M |
Shares Change (YoY) | +17.25% |
Shares Change (QoQ) | +0.33% |
Owned by Insiders (%) | 4.71% |
Owned by Institutions (%) | 59.20% |
Float | 51.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.62 |
Forward PS | 6.56 |
PB Ratio | 1.79 |
P/TBV Ratio | 1.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.00 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.24, with a Debt / Equity ratio of 0.14.
Current Ratio | 5.24 |
Quick Ratio | 5.16 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -149.00 |
Financial Efficiency
Return on equity (ROE) is -49.77% and return on invested capital (ROIC) is -28.92%.
Return on Equity (ROE) | -49.77% |
Return on Assets (ROA) | -15.25% |
Return on Invested Capital (ROIC) | -28.92% |
Return on Capital Employed (ROCE) | -28.74% |
Revenue Per Employee | $455,806 |
Profits Per Employee | -$467,938 |
Employee Count | 577 |
Asset Turnover | 0.22 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
Income Tax | 1.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.31% in the last 52 weeks. The beta is 0.83, so RCUS's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | -33.31% |
50-Day Moving Average | 14.18 |
200-Day Moving Average | 15.60 |
Relative Strength Index (RSI) | 34.34 |
Average Volume (20 Days) | 1,082,316 |
Short Selling Information
The latest short interest is 6.38 million, so 6.97% of the outstanding shares have been sold short.
Short Interest | 6.38M |
Short Previous Month | 7.75M |
Short % of Shares Out | 6.97% |
Short % of Float | 12.37% |
Short Ratio (days to cover) | 10.46 |
Income Statement
In the last 12 months, RCUS had revenue of $263.00 million and -$270.00 million in losses. Loss per share was -$3.14.
Revenue | 263.00M |
Gross Profit | -177.00M |
Operating Income | -298.00M |
Pretax Income | -246.00M |
Net Income | -270.00M |
EBITDA | -288.00M |
EBIT | -298.00M |
Loss Per Share | -$3.14 |
Full Income Statement Balance Sheet
The company has $1.09 billion in cash and $79.00 million in debt, giving a net cash position of $1.01 billion or $11.06 per share.
Cash & Cash Equivalents | 1.09B |
Total Debt | 79.00M |
Net Cash | 1.01B |
Net Cash Per Share | $11.06 |
Equity (Book Value) | 565.00M |
Book Value Per Share | 6.17 |
Working Capital | 912.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$158.00 million and capital expenditures -$11.00 million, giving a free cash flow of -$169.00 million.
Operating Cash Flow | -158.00M |
Capital Expenditures | -11.00M |
Free Cash Flow | -169.00M |
FCF Per Share | -$1.85 |
Full Cash Flow Statement Margins
Gross margin is -67.30%, with operating and profit margins of -113.31% and -102.66%.
Gross Margin | -67.30% |
Operating Margin | -113.31% |
Pretax Margin | -102.28% |
Profit Margin | -102.66% |
EBITDA Margin | -109.51% |
EBIT Margin | -113.31% |
FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.25% |
Shareholder Yield | -17.25% |
Earnings Yield | -26.65% |
FCF Yield | -16.68% |
Dividend Details Analyst Forecast
The average price target for RCUS is $31.11, which is 181.03% higher than the current price. The consensus rating is "Buy".
Price Target | $31.11 |
Price Target Difference | 181.03% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 42.02% |
EPS Growth Forecast (5Y) | -17.89% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of 0.36 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.36 |
Piotroski F-Score | 4 |